ERISA Ledger · U.S. DOL EBSA Form 5500 (2023)

Amryt Pharmaceuticals, INC.

Official 2023 U.S. DOL Form 5500 summary for Amryt Pharmaceuticals, INC. (Amryt Pharmaceuticals, INC. 401(k) Plan · EIN 20-2960116 · PN 001): $19.50M net assets, 55 active participants, and $34.69 per $10,000 (34.69 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAmryt Pharmaceuticals, INC.
Filing IdentifierAmryt Pharmaceuticals, INC. 401(k) Plan · EIN 20-2960116 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2023)$19.50M
Active Participants55
Direct Admin Fee Rate$34.69 per $10,000 (34.69 bps)
Cohort Peer Median$34.74 per $10,000 (34.74 bps)
Primary Recordkeeper / ProviderGallagher Fiduciary Advisors LLC
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI